As we assess what the Georgia General Assembly accomplished in its now-concluded 40-day session, one key bill that didn’t get passed was a missed opportunity to help many in our state: The push to expand availability of a cannabis oil derivative for those who endure seizure disorders. The bill would have allowed for the medicine’s carefully monitored manufacture and distribution to make it available to those who now must break the law to acquire it. It also would have expanded the number of diseases the oil is approved to treat.